Burning Rock Biotech Ltd (NAS:BNR)
$ 8.5999 0.5999 (7.5%) Market Cap: 882.26 Mil Enterprise Value: 797.85 Mil PE Ratio: 0 PB Ratio: 8.19 GF Score: 44/100

Q4 2020 Burning Rock Biotech Ltd Earnings Call Transcript

Mar 11, 2021 / 01:00PM GMT
Release Date Price: $302.6 (-6.14%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Burning Rock's 2020 Fourth Quarter and Full Year Earnings Conference Call.

Before we begin, I'd like to remind you that this conference call contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminologies such as will, expects, anticipates, future, intends, plans, believes, estimates, target, confident and similar statements. Statements that are not historical facts, including statements about Burning Rock's beliefs and expectations of forward-looking statements.

Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond Burning Rock's control. Forward-looking statements involve risks, uncertainties and other factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot